title: Metabolomics techniques in nanotoxicology studies.
abstract: The rapid growth in the development of nanoparticles for uses in a variety of applications including targeted drug delivery, cancer therapy, imaging, and as biological sensors has led to questions about potential toxicity of such particles to humans. High-throughput methods are necessary to evaluate the potential toxicity of nanoparticles. The omics technologies are particularly well suited to evaluate toxicity in both in vitro and in vivo systems. Metabolomics, specifically, can rapidly screen for biomarkers related to predefined pathways or processes in biofluids and tissues. Specifically, oxidative stress has been implicated as a potential mechanism of toxicity in nanoparticles and is generally difficult to measure by conventional methods. Furthermore, metabolomics can provide mechanistic insight into nanotoxicity. This chapter focuses on the application of both LC/MS and NMR-based metabolomics approaches to study the potential toxicity of nanoparticles.
authors.affiliation: Division of Systems Biology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. Laura.Schnackenberg@fda.hhs.gov
authors.forename: Laura K
authors.initials: LK
authors.lastname: Schnackenberg
authors.forename: Jinchun
authors.initials: J
authors.lastname: Sun
authors.forename: Richard D
authors.initials: RD
authors.lastname: Beger
mesh_terms: D000818:Animals; D002853:Chromatography, Liquid; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D055432:Metabolomics / Q000379:methods*; D053758:Nanoparticles / Q000633:toxicity*; D018675:Toxicity Tests / Q000379:methods*